Skip to content

IONS

Ionis Pharmaceuticals, Inc.

Key figures

MetricLast 12 months5-year CAGR
Revenue$960M+5.3%
Gross profit$943M+5.3%
Operating income−$565M—
Net income−$547M—
EPS−$3.56—
Free cash flow−$616M—